Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331M Sell
2,799,543
-27,775
-1% -$3.43M 0.05% 385
2025
Q4
$356M Buy
2,827,318
+17,687
+0.6% +$2.31M 0.06% 335
2025
Q3
$411M Sell
2,809,631
-300,855
-10% -$45.5M 0.06% 289
2025
Q2
$485M Sell
3,110,486
-29,892
-1% -$4.74M 0.08% 231
2025
Q1
$517M Buy
3,140,378
+1,340,411
+74% +$223M 0.1% 207
2024
Q4
$293M Buy
1,799,967
+539,058
+43% +$96.4M 0.05% 338
2024
Q3
$246M Buy
1,260,909
+265,496
+27% +$48.9M 0.05% 327
2024
Q2
$173M Buy
995,413
+57,780
+6% +$9.62M 0.04% 403
2024
Q1
$159M Sell
937,633
-31,713
-3% -$5.94M 0.04% 438
2023
Q4
$191M Buy
969,346
+77,712
+9% +$13.8M 0.06% 340
2023
Q3
$155M Sell
891,634
-68,430
-7% -$12.4M 0.05% 354
2023
Q2
$165M Buy
960,064
+221,264
+30% +$38.3M 0.06% 331
2023
Q1
$123M Buy
738,800
+121,083
+20% +$19.8M 0.04% 389
2022
Q4
$90.5M Buy
617,717
+129,429
+27% +$19.2M 0.03% 528
2022
Q3
$72.4M Sell
488,288
-171,616
-26% -$28.7M 0.03% 537
2022
Q2
$113M Sell
659,904
-53,074
-7% -$9.18M 0.05% 405
2022
Q1
$134M Sell
712,978
-171,408
-19% -$33.9M 0.04% 414
2021
Q4
$216M Buy
884,386
+53,389
+6% +$11.7M 0.06% 323
2021
Q3
$161M Buy
830,997
+247,709
+42% +$50M 0.05% 360
2021
Q2
$109M Sell
583,288
-237,122
-29% -$41.2M 0.04% 488
2021
Q1
$129M Buy
820,410
+114,779
+16% +$18.2M 0.04% 413
2020
Q4
$117M Buy
705,631
+43,562
+7% +$7.08M 0.04% 431
2020
Q3
$109M Sell
662,069
-54,107
-8% -$8.31M 0.04% 375
2020
Q2
$98.1M Sell
716,176
-464,931
-39% -$60.7M 0.04% 375
2020
Q1
$139M Sell
1,181,107
-85,065
-7% -$11.2M 0.07% 270
2019
Q4
$168M Buy
1,266,172
+391,131
+45% +$48.6M 0.06% 293
2019
Q3
$109M Buy
875,041
+141,788
+19% +$17.1M 0.04% 384
2019
Q2
$83.2M Buy
733,253
+12,832
+2% +$1.34M 0.03% 456
2019
Q1
$72.5M Buy
720,421
+57,038
+9% +$5.18M 0.03% 474
2018
Q4
$56.7M Sell
663,383
-443,077
-40% -$39.9M 0.03% 545
2018
Q3
$101M Buy
1,106,460
+167,884
+18% +$14.9M 0.04% 403
2018
Q2
$80M Buy
938,576
+192,954
+26% +$16.3M 0.03% 466
2018
Q1
$62.3M Sell
745,622
-143,214
-16% -$11.3M 0.03% 537
2017
Q4
$64M Buy
888,836
+325,303
+58% +$22.3M 0.03% 571
2017
Q3
$35.9M Sell
563,533
-159,180
-22% -$9.97M 0.02% 775
2017
Q2
$45.1M Buy
722,713
+249,264
+53% +$14.7M 0.02% 607
2017
Q1
$25.3M Buy
473,449
+92,947
+24% +$5.02M 0.01% 886
2016
Q4
$20.4M Buy
380,502
+127,768
+51% +$6.5M 0.01% 1011
2016
Q3
$13.1M Sell
252,734
-54,914
-18% -$2.78M 0.01% 1225
2016
Q2
$14.6M Sell
307,648
-443,775
-59% -$21M 0.01% 1132
2016
Q1
$33.3M Sell
751,423
-646,685
-46% -$27.4M 0.02% 619
2015
Q4
$67M Buy
1,398,108
+200,629
+17% +$9.07M 0.04% 412
2015
Q3
$49.3M Sell
1,197,479
-188,810
-14% -$8.76M 0.03% 471
2015
Q2
$66.8M Sell
1,386,289
-420,086
-23% -$20.1M 0.04% 424
2015
Q1
$83.6M Sell
1,806,375
-233,030
-11% -$10.5M 0.06% 357
2014
Q4
$87.8M Buy
+2,039,405
New +$82.8M 0.06% 324

Other funds holding ZTS

UBS Group's ZTS Position: Q1 2026 in Review

UBS Group reduced its Zoetis (ZTS) stake by 0.98% in Q1 2026, selling an estimated $3.43M and leaving 2,799,543 shares worth $331M. The position accounts for 0.05% of the portfolio, ranked #385.

UBS Group first reported a position in ZTS in Q4 2014 and has held it in 46 quarters since. The position peaked at $517M in Q1 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • UBS Group held 2,799,543 shares of Zoetis worth $331M as of Q1 2026.
  • UBS Group sold 27,775 Zoetis shares in Q1 2026, an estimated $3.43M.
  • Zoetis made up 0.05% of UBS Group's portfolio in Q1 2026, its #385 holding.
  • UBS Group first reported a position in Zoetis in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Zoetis position peaked at $517M in Q1 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.